000 01196 a2200349 4500
005 20250514184420.0
264 0 _c20040618
008 200406s 0 0 eng d
022 _a0893-8512
024 7 _a10.1128/CMR.17.2.370-389.2004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGiri, Malavika
245 0 0 _aDNA vaccines against human immunodeficiency virus type 1 in the past decade.
_h[electronic resource]
260 _bClinical microbiology reviews
_cApr 2004
300 _a370-89 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAIDS Vaccines
_xadministration & dosage
650 0 4 _aAnimals
650 0 4 _aDisease Models, Animal
650 0 4 _aDrug Design
650 0 4 _aHIV Infections
_xprevention & control
650 0 4 _aHIV-1
_xgenetics
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, SCID
650 0 4 _aMice, Transgenic
650 0 4 _aVaccines, DNA
_xadministration & dosage
700 1 _aUgen, Kenneth E
700 1 _aWeiner, David B
773 0 _tClinical microbiology reviews
_gvol. 17
_gno. 2
_gp. 370-89
856 4 0 _uhttps://doi.org/10.1128/CMR.17.2.370-389.2004
_zAvailable from publisher's website
999 _c14797987
_d14797987